SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Dermata Therapeutics, Inc. (DRMA)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
1.5 / 10
Letters
1
Latest Activity
Apr. 21, 2025
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Apr. 21, 2025 CORRESP Neutral/Informational Moderate Dermata Therapeutics, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by April 23, … Read Filing EDGAR
Apr. 21, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Dermata Therapeutics, Inc. that they will not review the company's registration statement filed on April 15, 2025. The letter emphasizes that the respo… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.